DYNE THERAPEUTICS INC shareholders Q2 2021

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 77 filers reported holding DYNE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.7%.

DYNE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,951,303$104,175,00019.37%
Vida Ventures Advisors, LLC 2,960,046$62,280,00015.62%
Logos Global Management LP 2,054,392$43,224,0003.63%
GREAT POINT PARTNERS LLC 672,559$14,151,0002.97%
Octagon Capital Advisors LP 583,649$12,280,0002.54%
COMMODORE CAPITAL LP 305,125$6,420,0002.24%
RA Capital Management 2,805,045$59,018,0000.95%
Altium Capital Management LP 166,636$3,506,0000.81%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 135,000$2,840,0000.75%
Soleus Capital Management, L.P. 178,360$3,753,0000.58%
SPHERA FUNDS MANAGEMENT LTD. 369,714$7,779,0000.53%
Vivo Capital, LLC 577,642$12,154,0000.53%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 787,000$16,558,0000.29%
Artal Group S.A. 525,000$11,046,0000.22%
HHLR ADVISORS, LTD. 1,000,000$21,040,0000.22%
EcoR1 Capital, LLC 215,000$4,524,0000.17%
HARVARD MANAGEMENT CO INC 107,252$2,257,0000.13%
Woodline Partners LP 222,374$4,679,0000.09%
Redmond Asset Management, LLC 12,513$263,0000.08%
Orbimed Advisors 350,000$7,364,0000.07%
External links

This page lists DYNE THERAPEUTICS INC's shareholders in Q2 2021. To view DYNE THERAPEUTICS INC's shareholder history, click here.